The first AlloVir trade was made in Q2 2021.
Since then Jim Simons bought shares seven more times and sold shares on seven occasions. The investor completely sold their stake between Q2 2024 and Q1 2025.
Avg closing price
Price range
Sold -16.5k shares
Q1 2025
Avg closing price
$9.79
Price range
$8.77
-
$10.96
Sold 51.1% shares (-17.3k shares)
Q4 2024
Avg closing price
$2.20
Price range
$0.45
-
$10.91
Sold 1.8% shares (-623 shares)
Q3 2024
Avg closing price
$0.76
Price range
$0.70
-
$0.82
Sold 8.2% shares (-3.06k shares)
Q2 2024
Avg closing price
$0.77
Price range
$0.72
-
$0.82
Increased shares by 13.1% (+4.33k shares)
Q1 2024
Avg closing price
$0.71
Price range
$0.64
-
$0.78
Increased shares by 128.3% (+18.6k shares)
Q4 2023
Avg closing price
$1.71
Price range
$0.68
-
$2.39
Increased shares by 8.7% (+1.16k shares)
Q3 2023
Avg closing price
$2.96
Price range
$2.15
-
$3.64
Sold 31.4% shares (-6.12k shares)
Q2 2023
Avg closing price
$4.13
Price range
$3.17
-
$5.82
Increased shares by 8.2% (+1.48k shares)
Q1 2023
Avg closing price
$5.54
Price range
$3.94
-
$7.05
Increased shares by 42.4% (+5.36k shares)
Q4 2022
Avg closing price
$7.37
Price range
$4.70
-
$9.98
Sold 3.7% shares (-482 shares)
Q3 2022
Avg closing price
$6.78
Price range
$4.13
-
$8.79
Increased shares by 468.3% (+10.8k shares)
Q2 2022